The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper

Work +86 21 3852 2111
Fax +86 21 3852 2000

Roy Chan

Work +86 21 3852 2111
DLA Piper LLP (US)

Work Department

Litigation & Regulatory


Roy heads DLA Piper's office in Shanghai and was responsible for its opening in October 2002. He is admitted to practice as a solicitor in England & Wales and Hong Kong. He joined DLA Piper in 1998 and has over 19 years' experience in handling corporate and regulatory matters for insurance companies and insurance and trade related contentious matters, he also represents multinational companies on investigations and compliance work. Roy has considerable experience in insurance and commercial related disputes that involve litigation and arbitration in Hong Kong, China, the United States and Europe (in particular the United Kingdom). He has further experience in commercial matters involving mergers and acquisitions, the sale and purchase of ships, ship/asset financings and insurance contracts. Roy advised Ping An Insurance (Group) Company of China on the Morgan Stanley and Goldman Sachs' investments in 1992, which were the first foreign investments in a Chinese insurance company. Roy has assisted many major Chinese enterprises in relation to their investments and corporate matters in both China and overseas markets.


Chinese (Mandarin and Cantonese), English.


Roy is a member of several major industry committees of foreign chambers of commerce in Shanghai.


The University of Leeds, Bachelor degree of Laws; The Chinese University of Hong Kong, Bachelor degree in Social Science.

China: Corporate and M&A

Corporate and M&A: foreign firms

Within: Corporate and M&A: foreign firms

Sectors of particular strength for¬†DLA Piper¬†include insurance, financial services and technology, and the practice acts for¬†a large number of global clients investing in the region as well as a significant share of outbound M&A work for Chinese clients.¬†It also fields lawyers with regulatory and compliance strength. The team recently acted for¬†Wanfeng Auto Holding Group in its ‚ā¨320m acquisition of Diamond Aircraft Industries and assisted¬†Sanpower Group with its successful $820m acquisition of US-based Dendreon Pharmaceuticals from Canada's Valeant group.¬†The key names in mainland China are¬†Roy Chan, who is a¬†leading corporate and M&A adviser to the insurance and financial services sectors in China;¬†Qiang Li, who is a highly rated¬†corporate and M&A and private equity specialist. Also highly regarded are¬†Stewart Wang¬†and James Chang, while in¬†Hong Kong¬†Luke Gannon¬†and Sheng Wu¬†are widely respected.

[back to top]

China: Healthcare and life sciences

Healthcare and life sciences: foreign firms

Within: Healthcare and life sciences: foreign firms

DLA Piper handles a mix of transactional and regulatory mandates for a number of global pharmaceutical, biotechnology and medical devices companies. Roy Chan and James Chang advised Ping An Healthcare and Technology Company on its pre-IPO restructuring; Chan was also part of a multi-jurisdictional team that advised China Ping An Insurance Overseas on its Chinese joint venture with Tsumura & Co. Shanghai-based Qiang Li assisted Sanpower Group with its $820m acquisition of Dendreon Pharmaceuticals. The team expanded with the arrival of William Fisher from Hogan Lovells International LLP who focuses on patents, trade secrets and IP-related transactions.

[back to top]

China: Shipping

Shipping: foreign firms

Within: Leading individuals

Roy Chan - DLA Piper

Within: Shipping: foreign firms

DLA Piper¬†is praised for providing¬†‚Äėaccurate assessment on the degree of legal and commercial risks in a timely manner'¬†and¬†demonstrating¬†'sound judgement in planning and managing contentious matters‚Äô. The ‚Äėexperienced, efficient and very knowledgeable‚Äô team is also singled out for its¬†'client-oriented approach‚Äô. Key individuals include Hong Kong-based litigation and regulatory practice head¬†Ernest Yang,¬†who is ‚Äėvery proficient, diligent and practical‚Äô and displays ‚Äėin-depth knowledge of the law as well as the shipping industry‚Äô; Kevin Chan¬†focuses on cross-border litigation and international arbitration; Roy Chan¬†advises on high-value shipping cases; and¬†counsel¬†Xiaoshan Chen.

[back to top]

Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.‚Ä©
    - DLA Piper UK LLP

Legal Developments in China

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to